• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Scopus
  4. Available and affordable complementary treatments for COVID-19: From hypothesis to pilot studies and the need for implementation
 
  • Details
  • Full
Options
2022
Journal Article
Title

Available and affordable complementary treatments for COVID-19: From hypothesis to pilot studies and the need for implementation

Abstract
Vaccination is a highly effective preventive measure against COVID-19. However, complementary treatments are needed to better control the disease. Fermented vegetables and spices, agonists of the antioxidant transcription factor nuclear factor (erythroid-derived 2)-like 2 (Nrf2) and TRPA1/V1 channels (Transient Receptor Potential Ankyrin 1 and Vanillin 1), may help in the control of COVID-19. Some preliminary clinical trials suggest that curcumin (spice) can prevent some of the COVID-19 symptoms. Before any conclusion can be drawn and these treatments recommended for COVID-19, the data warrant confirmation. In particular, the benefits of the foods need to be assessed in more patients, through research studies and large trials employing a double-blind, placebo-controlled design.
Author(s)
Bousquet, Jean
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Haahtela, T.
Skin and Allergy Hospital
Blain, H.
Centre Hospitalier Universitaire de Montpellier
Czarlewski, W.
MASK-air
Zuberbier, Torsten
Charité - Universitätsmedizin Berlin
Bedbrook, A.
MASK-air
Cru, A.A.
Universidade Federal da Bahia
Fonseca, J.A.
Faculdade de Medicina da Universidade do Porto (FMUP)
Klimek, L.
Head and Neck Surgery
Kuna, P.
Medical University of Lodz
Samolinski, B.
Medical University of Warsaw
Valiulis, A.
Medical Faculty of Vilnius University
Lemaire, A.
Centre Hospitalier de Valenciennes
Anto, J.M.
Hospital del Mar Medical Research Institute
Journal
Clinical and translational allergy  
Open Access
DOI
10.1002/clt2.12127
Additional link
Full text
Language
English
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Keyword(s)
  • broccoli

  • COVID-19

  • curcumin

  • Nrf2

  • TRP channel

  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024